The editorial highlights that integrating biology and genetics enables a shift towards precise, personalized cardiovascular diagnostics and therapy, improving risk assessment and treatment safety, although no quantitative clinical trial data are presented.
Editorial
R. Tzveova (Wed,) conducted a editorial in Cardiovascular disease patients, including those with genetic predispositions and molecular biological markers. The editorial highlights that integrating biology and genetics enables a shift towards precise, personalized cardiovascular diagnostics and therapy, improving risk assessment and treatment safety, although no quantitative clinical trial data are presented.